Biogen Inc. BIIB
Set alert
249.01 USD -4.61 -1.82%
At close · Nov 2
249.01 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
247.91 Day range 255.53
149.33 52-week range 253.84
- YTD
- +41.49%
- 1 year
- +61.41%
- Open
- 253.81
- Prev close
- 253.62
- Mkt cap
- 36.81B
- Vol
- 1.17M
- Avg vol
- 1.04M
- EPS
- 2.27
- P/E
- 109.70
- Div yield
- 0.00%
More statistics
- Low
- 247.91
- High
- 255.53
- Forward P/E
- 15.29
- Beta
- 0.09
- Short ratio
- 4.46
- Inst. own
- 99.78%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 5, 2027
- 50-d avg
- 227.08
- 200-d avg
- 201.18
- 1y target
- 264.23
5D chart
Events in this range
- Oct 28, 2026Earnings: 2.62; estimate 1.99; surprise 31.66%
- Oct 29, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Oct 29, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 29, 2026Rating: Argus Research · Hold → Buy
- Oct 29, 2026Rating: Canaccord Genuity · Buy → Buy
- Nov 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Nov 2, 2026Rating: Guggenheim · Buy → Buy
Signals (156)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 3:35 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 3:35 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 3:30 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 3:30 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:35 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 2:30 PM | 11 hours ago |
| MACD: Buy Signal | Nov 2, 2:30 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:05 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 2:00 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 1:30 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 12:40 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 12:35 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 12:30 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 12:05 PM | 14 hours ago |
| MACD: Buy Signal | Nov 2, 12:05 PM | 14 hours ago |
| MACD: Sell Signal | Nov 2, 12:00 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 11:55 AM | 14 hours ago |
| SMA: Bullish | Nov 2, 11:45 AM | 14 hours ago |
Newest 20 of 156.
Analyst view
Consensus: buy
Buy
Price target (mean) 264.23 +6.1% upside
Now 249.01
- Target (low)
- 175.00
- Target (mean)
- 264.23
- Target (high)
- 325.00
Ratings (0m) 36 25 buy · 10 hold · 1 sell
- Strong buy4
- Buy21
- Hold10
- Sell1
- Strong sell0
Recommendation trend
- This month 36
- 1 month ago 35
- 2 months ago 35
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.85 | 2.45 – 3.87 | 1.99 | +43.3% | 2.58B | +13.0% | 26 |
| Next quarter | 3.55 | 2.93 – 4.04 | 3.57 | -0.6% | 2.61B | +5.2% | 13 |
| Current year | 12.53 | 12.24 – 13.07 | 15.28 | -18.0% | 10.53B | +6.5% | 31 |
| Next year | 16.28 | 13.90 – 18.67 | 12.53 | +30.0% | 10.75B | +2.1% | 33 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Guggenheim | Maintained | Buy | Buy |
| Nov 2, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 29, 2026 | Argus Research | Upgrade | Hold | Buy |
| Oct 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | UBS | Maintained | Buy | Buy |
| Oct 29, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 29, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Oct 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Needham | Maintained | Buy | Buy |
| Oct 28, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 22, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 20, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 12, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Oct 9, 2026 | UBS | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 10, 2026 | HSBC | Maintained | Reduce | Reduce |
| Sep 3, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Aug 25, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 13, 2026 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| Aug 4, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 30, 2026 | UBS | Maintained | Buy | Buy |
| Jul 30, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 30, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |